StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / amber-tx.com

Amber Therapeutics (Bioinduction)

Amber Therapeutics (Bioinduction) (amber-tx.com): 2 changes recorded in its website history since November 2021. Homepage last checked 4 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. InvestorsBetween and

    Now shows investor logos: Oxford Science, NEA, Lightsone, F Prime, Intuitive and 8VC.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. ComplianceBetween and

    Now states ISO 13485 compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 30 November 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Amber TX | Developing Intelligent Bioelectrical Therapies

Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. June 2024 – November 2026 · 7 captures · latest observed messagingDoing the extraordinary ‍ to restore the ordinary

    Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.

    This wording observed 4 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 7 captures in this group
    • 11 June 2024 · Doing the extraordinary ‍ to restore the ordinary archived page
    • 3 August 2024 · Doing the extraordinary ‍ to restore the ordinary archived page
    • 8 January 2025 · Doing the extraordinary ‍ to restore the ordinary archived page
    • 12 August 2025 · Doing the extraordinary ‍ to restore the ordinary archived page
    • 7 January 2026 · Doing the extraordinary ‍ to restore the ordinary archived page
    • 13 June 2026 · Doing the extraordinary ‍ to restore the ordinary archived page
    • 4 November 2026 · Doing the extraordinary ‍ to restore the ordinary current websiteHistorical capture not publicly available
  2. November 2021 – August 2023 · 3 capturesAmber TX | Developing Intelligent Bioelectrical Therapies

    Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology

    This wording observed 18 August 2023.

    archived page
    Inspect 3 captures in this group
    • 30 November 2021 · Amber TX | Developing Intelligent Bioelectrical Therapies archived page
    • 27 January 2023 · Amber TX | Developing Intelligent Bioelectrical Therapies archived page
    • 18 August 2023 · Amber TX | Developing Intelligent Bioelectrical Therapies archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Amber Therapeutics highlights ISO 13485 and investor logos

Amber Therapeutics now states ISO 13485 compliance on its homepage and shows several investor logos, indicating emphasis on regulatory alignment and backing.

  • Between August 2023 and June 2024, Amber Therapeutics updated its homepage to state ISO 13485 compliance. [1]
  • Between August 2023 and June 2024, Amber Therapeutics began showing investor logos for Oxford Science, NEA, Lightsone, F Prime, Intuitive and 8VC. [2]
  • Reading: The presence of ISO 13485 compliance language and multiple investor logos between August 2023 and June 2024 suggests a focus on highlighting regulatory credentials and investor support. [1][2]

Cite this record

StartupHistory, “Amber Therapeutics (Bioinduction)” company record, https://startuphistory.org/c/amber-tx.com

Machine-readable: /c/amber-tx.com.json. How changes are found: method.